MediumCardiologyPrimary prevention hyperlipidaemia in high CVD riskau-amcau-racgpau-racp
A 60-year-old woman with no known cardiovascular disease attends her GP for a Heart Health Check. She is a non-smoker with treated hypertension (irbesartan 150 mg daily, clinic blood pressure 132/78 mmHg). Fasting lipids show total cholesterol 6.8 mmol/L and HDL cholesterol 1.1 mmol/L (TC:HDL ratio 6.2). Using the Australian CVD Risk Calculator, her 5-year absolute CVD risk is estimated at 12%. According to Australian guidelines, which pharmacological intervention is most appropriate to add now?